Egyptian Drug Authority (EDA) on Monday signed a cooperation protocol with Upjohn – one of Pfizer’s divisions and healthcare technology company Iqvia Egypt and Saudi Arabia – to automate the drug distribution process, notably drugs that require tight control.
The protocol is consistent with the role the private sector plays in Egypt’s development process, EDA’s deputy chairman said, adding that the protocol is also consistent with the company’s plan for digital transformation and the automation of its services.
As for to chairman of Upjohn Egypt Mohamed Swilam, he stressed the The importance of providing sustainable solutions for all healthcare partners that can improve patients’ lives, add value to the healthcare systems, and reinforce the healthcare infrastructure in Egypt.
The cooperation protocol also aims to support the EDA in establishing a robust automated system for drug distribution and boost public-private partnership and cooperation with Egypt’s government, notably in digital transformation and healthcare automation, Swilam announced.
Director-General of Iqvia Egypt and Saudi Arabia Mohamed Mostafa said that the
The company is eager to support the government’s efforts in digital transformation, director-general of Iqvia Egypt and Saudi Arabia Mohamed Mostafa said.
Iqvia is committed to participating in the EDA’s operations and plans including developing android and IOS apps for mobile phones, Mostafa added.